Health CanadaGeneral Alert
ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis
Published: March 16, 2018Recall ID: 60756Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis
Recalling Firm: Marketed health products
Reason for Recall / Hazard
Product safety
Product Description & Identification
ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis
Additional Source Details
| Field | Value |
|---|---|
| N I D | 60756 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/zinbryta-daclizumab-beta-voluntary-withdrawal-canada-due-risk-encephalitis |
| Issue | Product safety |
| Title | ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis |
| Archived | 0 |
| Category | Biologic or vaccine |
| Last updated | 2018-03-16 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis Check if your household is affected: https://therecallfile.com/recalls/zinbryta-daclizumab-beta-voluntary-withdrawal-in-canada-due-to-risk-of/CANADA-60756
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis